Your browser doesn't support javascript.
loading
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
Umbricht, Daniel; Del Valle Rubido, Marta; Hollander, Eric; McCracken, James T; Shic, Frederick; Scahill, Lawrence; Noeldeke, Jana; Boak, Lauren; Khwaja, Omar; Squassante, Lisa; Grundschober, Christophe; Kletzl, Heidemarie; Fontoura, Paulo.
Afiliación
  • Umbricht D; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Del Valle Rubido M; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Hollander E; Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center Bronx, New York, NY, USA.
  • McCracken JT; Psychiatry and Biobehavioral Sciences, CART, UCLA Semel Institute, Los Angeles, CA, USA.
  • Shic F; Child Study Center, Yale University, New Haven, CT, USA.
  • Scahill L; Department of Pediatrics, Emory University, Marcus Autism Center, Atlanta, GA, USA.
  • Noeldeke J; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Boak L; Roche Product Development Neuroscience, Basel, Switzerland.
  • Khwaja O; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Squassante L; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Grundschober C; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Kletzl H; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann - La Roche, Ltd., Basel, Switzerland.
  • Fontoura P; Roche Product Development Neuroscience, Basel, Switzerland.
Neuropsychopharmacology ; 42(9): 1914-1923, 2017 Aug.
Article en En | MEDLINE | ID: mdl-27711048
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicotrópicos / Compuestos de Espiro / Trastorno del Espectro Autista / Indoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psicotrópicos / Compuestos de Espiro / Trastorno del Espectro Autista / Indoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido